Search Results - "Lertsanguansinchai, P."

High frequency of mutation of epidermal growth factor receptor in lung adenocarcinoma in Thailand by Sriuranpong, V., Chantranuwat, C., Huapai, N., Chalermchai, T., Leungtaweeboon, K., Lertsanguansinchai, P., Voravud, N., Mutirangura, A.

“…Recent reports have suggested influences of racial difference on the frequency of mutation of EGFR in lung cancer. We therefore sought to characterize the…”
Get full text

Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma by Zhu, Guopei, Lin, Jin-Ching, Kim, Sung-Bae, Bernier, Jacques, Agarwal, Jai Prakash, Vermorken, Jan B, Thinh, Dang Huy Quoc, Cheng, Hoi-Ching, Yun, Hwan Jung, Chitapanarux, Imjai, Lertsanguansinchai, Prasert, Reddy, Vijay Anand, He, Xia

“…With increasing numbers of patients with unresectable locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) receiving…”
Get full text

Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial by Lorvidhaya, Vicharn, Chitapanarux, Imjai, Sangruchi, Supatra, Lertsanguansinchai, Prasert, Kongthanarat, Yongyut, Tangkaratt, Saipin, Visetsiri, Ekachai

“…This is a prospective, Phase III multicenter randomized trial to assess the effectiveness of concurrent intravenous mitomycin C, oral 5-fluorouracil (5-FU),…”
Get more information

Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma by Lertsanguansinchai, Prasert, Lertbutsayanukul, Chawalit, Shotelersuk, Kanjana, Khorprasert, Chonlakiet, Rojpornpradit, Prayuth, Chottetanaprasith, Taywin, Srisuthep, Apiradee, Suriyapee, Sivalee, Jumpangern, Chotika, Tresukosol, Damrong, Charoonsantikul, Chulee

“…Intracavitary brachytherapy plays an important role in the treatment of cervical carcinoma. Previous results have shown controversy between the effect of dose…”
Get more information

Capecitabine (X) and radiotherapy (RT) in locally advanced squamous carcinoma of the uterine cervix: Phase II results by Domingo, E., Lorvidhaya, V., De Los Reyes, R., Sy Ortin, T., Kamnerdsupaphon, P., Lertbutsayanukul, C., Vito-Cruz, E., Taravichitkul, E., Cupino, N., Lertsanguansinchai, P.

“…Abstract only…”
Get full text

174 A phase II study of capecitabine in patients who have failed first-line treatment for locally advanced or metastatic cervix cancer (MCC) by Lorvidhaya, V., Phromratanapongs, P., Chitapanarux, I., Kamnerdsupaphon, P., Lertsanguansinchai, P., Hsieh, C.Y., Kongthanarat, Y., Visetsiri, E.

Get full text

Intracranial germ cell tumors: experience in King Chulalongkorn Memorial Hospital by Shotelersuk, K, Rojpornpradit, P, Chottetanaprasit, T, Lertbutsayanukul, C, Lertsanguansinchai, P, Khorprasert, C, Asavametha, N, Suriyapee, S, Jumpangern, C

“…A retrospective study was performed on 69 patients with intracranial germ cell tumors who were treated at the Division of Radiation Oncology, Department of…”
Get more information

13-cis-retinoic acid and interferon-alpha 2a therapy in locally advanced squamous cell carcinoma of the cervix: p53 alteration, proliferating cell nuclear antigen expression and angiogenesis response by Charuruks, N, Voravud, N, Termrungruanglert, W, Lertsanguansinchai, P, Tresukosol, D, Niruthisard, S, Sirisabya, N

“…To evaluate prognostic importance of p53, PCNA and vascularization alteration in patients with locally advanced cervical squamous cell carcinoma (SCC) after…”
Get full text

Results of radiation therapy in stage 1B cervical carcinoma at King Chulalongkorn Memorial Hospital: fifteen-year experience by Lertbutsayanukul, C, Lertsanguansinchai, P, Shotelersuk, K, Khorprasert, C, Rojpornpradit, P, Asavametha, N, Pataramontree, J, Suriyapee, S, Tresukosol, D, Termrungruanglert, W

“…A retrospective study was performed on 131 patients with stage 1B cervical carcinoma who were referred and treated with external beam radiation and…”
Get more information

Phase II study of concurrent chemoradiotherapy for inoperable (bulky) stage III (A/B) non-small cell lung cancer (NSCLC): a preliminary report by Ratanatharathorn, V, Lorvidhaya, V, Kraipiboon, P, Sirachainan, E, Maoleekoonpairoj, S, Phromratanapongse, P, Cheirsilpa, A, Tangkaratt, S, Srimuninnimit, V, Pattaranutaporn, P, Lertsanguansinchai, P

“…We designed a phase II study to determine the feasibility and toxicity of concomitant radiotherapy and Paclitaxel/Carboplatin followed by adjuvant chemotherapy…”
Get more information